Navigating The Regulatory Environment For CBD Marketing
Law360 (December 9, 2019, 4:47 PM EST) -- Countless products infused with CBD are suddenly appearing everywhere, including on the internet. Companies are marketing CBD oil and CBD-infused products for a wide range of medical issues, from anxiety, depression, insomnia and pain relief, to diabetes, heart disease and neurological disorders like Parkinson's disease and epilepsy.
These marketing strategies and medical claims have caught the attention of regulators including the U.S. Food and Drug Administration and the Federal Trade Commission.
As an initial matter, the FDA has stated that the only FDA-approved product containing CBD is a seizure medication, Epidiolex. According to the FDA, all other ingestible CBD products are...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!